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Transcription activator-like effector nucleases (TALENs) are pro-
grammable nucleases that join FokI endonuclease with the
modular DNA-binding domain of TALEs. Although zinc-ﬁnger
nucleases enable a variety of genome modiﬁcations, their appli-
cation to genetic engineering of livestock has been slowed by
technical limitations of embryo-injection, culture of primary cells,
and difﬁculty in producing reliable reagents with a limited budget.
In contrast, we found that TALENs could easily be manufactured
and that over half (23/36, 64%) demonstrate high activity in
primary cells. Cytoplasmic injections of TALEN mRNAs into live-
stock zygotes were capable of inducing gene KO in up to 75% of
embryos analyzed, a portion of which harbored biallelic modiﬁca-
tion. We also developed a simple transposon coselection strategy
for TALEN-mediated gene modiﬁcation in primary ﬁbroblasts that
enabled both enrichment for modiﬁed cells and efﬁcient isolation
of modiﬁed colonies. Coselection after treatment with a single
TALEN-pair enabled isolation of colonies with mono- and biallelic
modiﬁcation in up to 54% and 17% of colonies, respectively. Cose-
lection after treatment with two TALEN-pairs directed against the
same chromosome enabled the isolation of colonies harboring
large chromosomal deletions and inversions (10% and 4% of col-
onies, respectively). TALEN-modiﬁed Ossabaw swine fetal ﬁbro-
blasts were effective nuclear donors for cloning, resulting in the
creation of miniature swine containing mono- and biallelic muta-
tions of the LDL receptor gene as models of familial hypercholes-
terolemia. TALENs thus appear to represent a highly facile
platform for the modiﬁcation of livestock genomes for both bio-
medical and agricultural applications.
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The ability to knockout or precisely alter genes is fundamentalfor determining gene function and genetic engineering. For
livestock, gene-KO strategies enable reﬁnement of traits for
xenotransplantation and biomedical products (1) and have been
used to produce valuable models of human disease (2). There
are further objectives in animal agriculture that would beneﬁt
from gene-KO, including functional characterization of high-
impact genes identiﬁed in association studies, engineering dis-
ease resistance, reducing the threat of zoonotic disease trans-
mission, alteration of production traits, and enhancement of
animal welfare. Until recently, homologous recombination (HR)
in primary ﬁbroblasts followed by somatic-cell nuclear transfer
was the exclusive method for the production of KO pigs and
cattle. However, generation of KO cell lines by HR is inefﬁcient
and the length of time for gestation and reproductive maturation
for livestock represent signiﬁcant barriers to homozygous gene
inactivation or the engineering of multiple loci. In addition, HR
often requires the use of a linked selection-marker, which can
confound functional studies (3) and complicate regulatory ap-
proval of engineered food products.
Zinc ﬁnger nucleases (ZFNs) offer an alternative platform for
germ-line KO. ZFNs are fusion proteins consisting of a modular
DNA-binding domain tethered to a FokI endonuclease mono-
mer. When two ZFNs bind their target in an appropriate ori-
entation, FokI monomers can dimerize and introduce a DNA
double-strand break (4). Lesions are often repaired by non-
homologous end-joining (NHEJ) that typically results in small
insertions or deletions (indels) (5), two-thirds of which cause
a frame-shift that disables encoded proteins. Thus, in contrast to
HR, where genes are disabled by targeted introduction of se-
lection cassettes, ZFNs disable genes without introduction of
exogenous DNA. Generation of germ-line KO has been suc-
cessful in many model animal systems (6) as well as in pigs (7, 8).
Particularly exciting in livestock was the report of ZFN-medi-
ated, biallelic KO of the porcine GGTA1 gene using commercial
ZFN reagents (9), wherein biallelic-null cells could be enriched
by FACS for the absence of a GGTA1-dependent surface epi-
tope. Double-strand DNA breaks dramatically enhance HR (10),
leading to homology-dependent repair of ZFN lesions for pre-
cise gene alteration in human cells (11), mice, and rats (12, 13).
Although the potential of ZFN genome modiﬁcation of livestock
is great, design and assembly is labor-intensive and limited by
available target sites (6).
Transcription activator-like effector nucleases (TALENs), like
ZFNs, consist of assembled DNA-binding motifs coupled to the
FokI nuclease (6, 14). Active, custom-designed TALENs have
been reported to induce indel frequencies between 2% and 55%
of targeted chromosomes (15, 16). As with ZFNs, TALEN-me-
diated double-strand breaks also stimulate HR in human cells at
levels similar to those achieved with ZFNs (11, 15). Most im-
portantly, TALENs appear to be superior to ZFNs in terms of
simple and straightforward design and assembly strategies (17),
such that manufacture of effective TALENs is signiﬁcantly
cheaper and faster than effective ZFNs. Here, we demonstrate
efﬁciency and versatility of TALENs for a variety of genome
modiﬁcations to livestock genomes. We have achieved mono-
and biallelic KO of genes and large chromosomal rearrange-
ments. Finally, toward our goal of producing a large animal
model of atherosclerosis, we’ve used TALENs to develop
Ossabaw miniature swine (18) containing inactivating alleles of
the LDL receptor (LDLR) gene. To our knowledge, this report
of genetic engineering and cloning of these valuable biomedical
animals is unique, and is also a unique example of TALEN-
mediated gene modiﬁcation of livestock.
Results
Evaluation of TALENs in Livestock Embryos.We chose to characterize
TALEN efﬁciency for precise alteration of genomes in livestock
embryos by using in vitro-prepared bovine and porcine embryos.
Three pairs of TALENs were generated using the +231 TALEN
scaffold (17, 19) (Fig. 1). In vitro-transcribed mRNA encoding
each TALEN-pair was injected into the cytoplasm of bovine
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embryos (≥50 embryos per condition) at ∼19 h postfertilization
and were cultured in vitro until blastocyst stage (Table S1).
Whole-genome ampliﬁcation (WGA) and genotypic analysis
revealed indels in one blastocyst injected with ACAN11 and ﬁve
injected with ACAN12 TALENs (Fig. 1B and Table S1); how-
ever, development was signiﬁcantly impaired in conditions with
the greatest indel frequency (max indel frequency ∼10%) (Table
S1). Two groups have reported enhancement in TALEN activity
using different N- and C-terminal truncations of the native
TALE protein (15, 20). Thus, we created a truncated TALEN
scaffold (GoldyTALEN, GT) compatible with the Golden Gate
cloning procedure reported in Cermak et al. (17) (Fig. 1A) for
use in subsequent experiments. An additional TALEN-pair,
GDF83.1, was developed using the GT scaffold. Zygotes were
injected with TALEN mRNA plus 2 ng/μL of EGFP mRNA as
an indicator of successful injection. Indel analysis was performed
on individual blastocysts by direct sequencing of PCR amplicons
spanning the TALEN recognition site (Fig. S1). Mutation fre-
quency of GT-GDF83.1 TALENs signiﬁcantly exceeded pre-
vious injections. Six of 14 blastocysts (43%) injected with a low
mRNA dosage (2 ng/μL) displayed indels without a signiﬁcant
reduction in development rate (Table S1). Three of four blas-
tocysts in the high-dosage group (10 ng/μL) displayed indels,
with biallelic modiﬁcation occurring in two of three mutant
blastocysts (Fig. 1B).
A single set of injections was also conducted in porcine zygotes
using TALENs targeted to the porcine RELA gene (p65) for
which a tolerance allele for African Swine Fever has been pro-
posed (21). Zygotes were injected with a mixture, including 20
ng/μL of TALEN mRNA along with 5 ng/μL of EGFP mRNA as
an indicator of successful injection. In contrast to bovine injec-
tions, where all EGFP injected embryos ﬂuoresced, only 35% (71
of 214) were EGFP+. WGA and PCR ampliﬁcation was suc-
cessful from 56 of the EGFP+ embryos, and 16 of these (29%)
revealed indels by Surveyor assay or sequence analysis. One-third
of the mutants (6 of 16) were either homozygous or heterozygous
biallelic mutants (Fig. 1B).
TALEN Function in Livestock Fibroblasts. Although our in vitro data
demonstrates that direct embryo modiﬁcation is likely to be a
viable approach to livestock genome modiﬁcation, the need to
engineer alleles precisely led us to explore TALEN function in
cultured livestock cells to meet two objectives: (i) to serve as a
quality control measure for assembled TALEN-pairs before in-
jection and (ii) to develop methods for TALEN-mediated ge-
netic modiﬁcation of livestock by cloning. To determine the best
TALEN architecture for livestock ﬁbroblasts, binding domains of
six TALEN-pairs were placed in the context of the +231 and GT
scaffolds (Fig. 1A). Each TALEN-pair was transfected into pri-
mary livestock ﬁbroblasts, and the efﬁciency of genome modiﬁ-
cation was measured at day 3 by the Surveyor assay. The most
active TALEN-pairs, DMDE7.1 and ACAN12, displayed cleav-
age efﬁciencies of 38% and 25% (Fig. 2A). The TALEN scaffold
had a signiﬁcant effect on nuclease activity in ﬁbroblasts. In total,
four of six loci targeted with the GT scaffold cleaved at 3.5% or
greater but only the DMDE7.1 TALEN-pair cleaved above 1%
with the +231 scaffold (Fig. 2). As noted in previous studies (15,
22), a 72-h incubation at 30 °C after transfection had a positive
effect on target cleavage in livestock ﬁbroblasts. We applied
these ﬁndings to the design and testing of additional TALEN-
pairs. In total, 23 of 36 (64%) TALEN-pairs were detectably
active (> 1.0% NHEJ) at 15 genes scattered across the pig and
cow genomes (autosomes and sex chromosomes) (Table S2).
Three-quarters of the active pairs cleaved with high efﬁciency
(19–40% NHEJ), with an average of 25%.
Extended Culture and Indel Enrichment by Transposon Cotransfection.
An ideal resource for cloning would be cell populations in which
the majority of cells harbor indels that remain stable over extended
periods in culture. Although an average genomicmodiﬁcation level
of 25% (i.e., ∼44% of cells with at least one modiﬁed allele; cal-
culations described in Table 1) would be reasonable for direct so-
matic-cell nuclear transfer of cell populations, a method to enrich
for modiﬁed cells or isolation of speciﬁc modiﬁed clones would be
useful. To this end, we evaluated the stability of cells containing
indels after an extended period in culture and tested an indel en-
richment strategy based on transposon coselection (23). To apply
this approach to TALEN-gene modiﬁcation, a Sleeping Beauty
transposon carrying a selection marker plus SB100X transposase
was added to transfections with TALEN-encoding plasmids at
a ratio of 1:5. Transient TALEN expression and transposon
integration can only occur in cells that have been successfully
Fig. 1. TALEN activity in bovine embryos. (A) TALENs for embryo injection
generated in either the +231 or GT scaffold. Each scaffold shares a common
SV40 nuclear localization signal (NLS) and C-terminal fusion of the FokI
homodimer domain. Numbering is relative to the DNA-binding domain; the
amino acid before the ﬁrst repeat variable di-residue repeat (RVD) is labeled
“−1” and the amino acid following the last RVD repeat is labeled “+1.”
Bovine or swine, in vitro-produced zygotes were injected with TALEN mRNA
on day 1 (D1) and cultured in vitro to blastocyst formation. Individual blas-
tocysts (blasts) were collected on day 8, subjected to WGA, and analyzed for
indels. (B) TALEN-mediated indels in bovine (ACAN12 and GDF83.1 injected)
and porcine (p65-11.1 injected) embryos. Wild-type sequence is shown above
with TALEN binding sites underlined. Both deletion and insertion (denoted
with an “i” and number of base pairs) events were identiﬁed. Mismatch
bases are indicated by lowercase text. Only biallelic modiﬁcations are shown
for GDF83.1 and p65-11.1 embryos. Embryos with a homozygous indel (same
indel on each allele) are shown on a single line. Indel alleles of compound
biallelic embryos (two or more unique indel alleles) are displayed on mul-
tiple lines (e.g., 1a, 1b). Some blastocysts were partially mosaic. Sequence
analysis of embryos 1 and 2 injected with bovine GDF83.1 TALENs revealed
three unique indel alleles each; the number of reads for each allele is noted
to the right of the sequence. In addition to indel alleles, 3 and 1 wild-type
sequence reads were observed for GDF83.1 embryos 1 and 2, respectively.
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transfected, thus providing a mechanism for enrichment for
transfected cells. In addition, selection is an extremely reliable
method for clonal isolation in primary ﬁbroblasts, a cell type averse
to low culture density and dilutional cloning (24).
We ﬁrst evaluated cotransfection with Mirus LT1, a commonly
used cationic lipid transfection reagent. Whereas gene modiﬁca-
tion was below detection 14 d posttransfection without selection,
genome modiﬁcation levels in transposon-selected populations
were 31%, 13%, and 20% for DMD7.1, DMD6, and LDLR2.1
TALEN-pairs, respectively (Fig. 3). Thus, despite low-transfection
efﬁciency with cationic lipids (<5% for this experiment), efﬁcient
modiﬁcation can be achieved using transposon coselection. We
next applied transposon coselection to cells transfected by nucle-
ofection where >90% transfection efﬁciency is routine. Without
selection, the proportion of cells modiﬁed after 14 d in culture was
50–90% lower than levels measured at day 3, suggesting an attri-
tion of modiﬁed cells. In contrast, transposon coselection was in all
cases effective for maintenance of modiﬁed cells transfected by
nucleofection but, with the exception of ACAN12, did not signif-
icantly increase the frequency of modiﬁed cells (Fig. 3C). Trans-
poson coselection thus appears to be an effective enrichment
method when transfection efﬁciency is low and an effective
maintenance method when transfection efﬁciency is high.
Isolation of Mono- and Biallelic KO Clones. We have previously
shown that transgenic primary ﬁbroblast colonies can reliably be
isolated and expanded when plated with wild-type ﬁbroblasts and
subjected to drug selection using transposon coselection (23). To
evaluate this approach, we isolated puromycin-resistant colonies
from cells treated with six TALEN-pairs and evaluated their
genotypes by the Surveyor assay or direct sequencing of PCR
products spanning the target site (Table 1). The proportion of
indel-positive clones was similar to our predictions calculated
from the percent NHEJ measured in the parent populations 3 d
after transfection (Table 1). Biallelic modiﬁed clones were
identiﬁed for ﬁve of six TALEN-pairs, occurring in up to 35% of
indel-positive cells (Table 1). Notably, among modiﬁed clones,
the frequency of biallelic modiﬁcation exceeded predictions
based on day 3 modiﬁcation levels and the assumption that each
chromosome cleavage/repair would be an independent event
(observed 17–35% vs. predicted 10–16%). Among clones with
biallelic modiﬁcations, a signiﬁcant portion (15 of 23, 65%), were
homozygous for the same indel, suggesting that sister chromatid
exchange may be common (Fig. S2).
Chromosomal Deletions and Inversions with TALENs. We next in-
vestigated whether the simultaneous delivery of two TALEN-
pairs targeting the same chromosome could induce either large
chromosomal deletions or inversions. We chose TALEN-pairs
DMDE6 and DMDE7.1 because a high percentage of Duchene’s
Muscular Dystrophy (DMD) is caused by gross deletions (25),
providing the opportunity to mimic the human condition in
a porcine model. Day 3 gene-modiﬁcation levels were high for
each TALEN-pair (24% for DMDE6 and 23% DMDE7.1), al-
beit slightly lower than when either TALEN-pair was transfected
Fig. 2. Comparison of TALEN scaffolds for gene-editing in livestock ﬁbro-
blasts. (A) The Surveyor assay was conducted on transfected ﬁbroblasts
transfected with either DMDE7.1 or ACAN12 TALEN-pairs. Scaffold and
temperature treatment is indicated above the gel and percent NHEJ is in-
dicated below. NT, not treated. (B) Activity of four additional TALEN-pairs,
identiﬁed at the bottom of each matrix, with either the +231 or GT scaffold
(left column in each matrix) at either 30 or 37 °C.
Table 1. Genotype distribution in ﬁbroblast clones
TALEN-pair
% NHEJ day 3
(Surveyor)
Predicted %
mod clones
Predicted %
biallelic mod
Observed mod
clones (%)
Observed biallelic
mod (%)
LDLRE2.1 Pig ♂ 19 34.5 10.5 30/81 (37) 5/26 (19)
LDLRE2.1 Pig ♀ 21.5 38.3 12 23/76 (30) 8/23 (35)*
LDLRE2.1 Pig ♂ 14.4 26.7 7.7 12/94 (13) 2/12 (≥17)†
LDLRE2.1-2x‡ Pig 19.7 35.5 10.9 8/24 (33) 2/8 (≥25) †
LDLRE4.2 Pig ♂ 20 36 11.1 4/48 (8.3) 1/4(25) †
LDLRE4.2 Pig ♀ 19 34.4 10 8/47 (17) 0/8†
DMDE6 Pig 25 43.8 15.6 17/35 (49) -
DMDE7.1 Pig 27 47 15.6 12/29 (41) 3/10 (30)
DMDE7.1-2x‡ Pig 22 39.2 12.4 22/41 (54) 7/22 (≥32)*†
GHRHR2.3 Pig 29 50 17 26/43 (60) 15/26 (≥58)*§
ACAN12 Cow 29 50 17 27/35 (77) 2/6 (NA) {
btGDF83.1 Cow 17 31 9.3 7/24 (29) 0/7
If chromosome modiﬁcation is an independent event, the frequency of biallelic modiﬁcation can be predicted by the following equation: biallelic = (day
3% NHEJ)2. By the same assumption, monoallelic modiﬁcations (mod) can be predicted by this equation: monoallelic modiﬁcation = (day 3% NHEJ × 2) × (1 −
day 3% NHEJ). Expected % mod clones (both mono- and biallelic) was calculated by summing mono- and biallelic modiﬁcation proportions derived from the
equations above.
*A 95% Conﬁdence interval exceeds expected biallelic-null hypothesis that cleavage and repair are of each chromosome is an independent event.
†Biallelic KO were identiﬁed by sequencing of PCR products. Only overlapping or homozygous deletions can be identiﬁed using this technique.
‡Fibroblasts were transfected and recovered twice within 2 wk with the same TALEN-pair.
§Five of 15 biallelic colonies were conﬁrmed as double frame-shift alleles.
{Only colonies with distinguishable gross deletions in the PCR amplicon were analyzed.
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individually (Fig. 4B). To determine if the sequence between the
two TALEN-pairs had been deleted, we designed PCR primers
to span this region. If the 6.5-kb sequence had been removed, we
expected to see a PCR product of ∼500 bp. A fragment ap-
proximating 500 bp was observed in replicates in which both
TALEN-pairs were introduced, but was absent when either
TALEN-pair was introduced alone (Fig. 4C). We next assayed
the cell population for inversion events by PCR ampliﬁcation
across presumptive new 5′- and 3′-junctions. Products were ob-
served at the expected sizes for both the 5′- and 3′-junctions of
the predicted inversion, but only when both TALEN-pairs were
introduced (Fig. 4D). Both deletion and inversion events were
recovered at relatively high frequencies (10.3% and 4.1%, re-
spectively; n > 1,000) (Table S3) in colonies generated using the
transposon coselection strategy. Deletion and inversion events
occurred with remarkable ﬁdelity, with 41 of 43 (95%) of puta-
tive inversion-positive colonies conﬁrmed by PCR ampliﬁcation of
both the 5′- and 3′-junctions. Sequencing of PCR products con-
ﬁrmed both deletion and inversion events with addition or de-
letion of very few nucleotides at their junctions (Fig. S3).
Production of TALEN-Modiﬁed Swine by Cloning. Having demon-
strated the ability to efﬁciently generate knockouts, gross dele-
tions, and inversions in vitro, we next sought to examine the
utility of TALEN-modiﬁed swine cells for animal production.
Transposon coselected Ossabaw swine colonies with mono- and
biallelic modiﬁcation of the class A domain 1 of the LDLR gene
were pooled disproportionately (pool A, four genotypes; pool B,
three genotypes; pool C, ﬁve genotypes) and cloned by chro-
matin transfer (26). Pregnancy was established in seven of nine
transfers (one of two for pool A, two of three for pool B, and four
of four for pool C). Six pregnancies were maintained to term,
resulting in 18 live-born piglets, including one stillborn from pool
A, nine healthy and two stillborn piglets from pool B, and eight
healthy, one stillborn, and one euthanized (because of a cloning
defect) piglets from pool C (Fig. 5A). At 60+ days 17 piglets
remained in good health. In total, four of eight colony genotypes
from pools B and C were represented in cloned offspring. Ten of
the 11 piglets from pool B carried biallelic modiﬁcations of
LDLR (B1) (Fig. 5) derived from a colony harboring both an
insertion-induced frame-shift (289_290ins34) in one allele and
a 3-bp deletion (285_287delATG) in the other allele, the former
prematurely truncating the LDLR ORF, the latter removing
a universally conserved aspartic acid residue (D47del) implicated
in familial hypercholesterolemia (27, 28). A second colony geno-
type from pool B (B2; 211_292del128) was observed in a stillborn
piglet. Two of ﬁve colony genotypes were represented in piglets
from pool C, including 289_290del10 and 289_290insA, each
resulting in frame-shift mutations expected to prematurely truncate
the LDLR ORF.
Fig. 3. Transposon coselection for indel enrichment. (A) The experimental
timeline. Day zero (D0), cells were transfected with a mixture of plasmids,
including an expression cassette for each TALEN, a transposon encoding a
selection marker, and transposase expression cassette. Transfected cells were
cultured for 3 d at either 30 or 37 °C before splitting, collection of a sample
for Surveyor assay, and replating for extended culture with and without
selection for transposon integration. Cells cultured for 14+ d were collected
for Surveyor assay. (B) Fibroblasts were transfected using Mirus LT1 reagent
and Surveyor assay was performed on day 14 populations. Temperature
treatment, selection and TALEN identiﬁcation (identiﬁed by single letters
(A, B, and C) as indicated in C are shown above the gel. (C) Fibroblasts were
transfected by nucleofection and the percent NHEJ was measured at day 3,
and in day 14 nonselected (NS) and selected (S) populations. Temperature
treatment is indicated above each matrix. ND, not detected; WT, wild-type
amplicon, Surveyor-treated.
Fig. 4. TALEN-induced deletions and inversions. (A) DMD locus. Transcrip-
tional orientation is denoted by black chevrons in intron-6. (B) Surveyor
assay of cells transfected simultaneously with TALENs targeted to exon 6 and
7 reveal NHEJ indels at both sites. (C) PCR with primers (black arrows)
ﬂanking the presumptive deletion yield a ∼500-bp product when both exon-
6 and exon-7 TALENs were introduced simultaneously, but not when trans-
fected singly. (D) The predicted outcome of an inversion event of the se-
quence between the TALEN target sites. Primers ﬂanking the presumptive
ﬂanking sites at the 5′- and 3′-ends of the inversion locus are shown (black
arrows) along with predicted product size. PCR products were observed at
both 5′- and 3′-junctions only when both exon-6 and exon-7 TALENs were
introduced simultaneously.
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Discussion
Our examination of TALEN activity in livestock embryos pro-
duced some intriguing results. First, only one-third of pig zygotes
cytoplasmically injected with the TALEN/EGFP mRNA ﬂuo-
resced at a detectable level. Although this low rate was un-
expected, others have reported similar ﬁndings by either EGFP
mRNA injections of porcine oocytes (29, 30) or cytoplasmic in-
jection of plasmids into bovine zygotes (31). In contrast, all
EGFP-injected bovine embryos ﬂuoresced. Pig and cattle injec-
tions took place at different locales; thus, we are unable to
conclude whether this difference is a result of technical or spe-
cies-speciﬁc differences. Regardless, we speculate that selecting
for EGFP+ embryos will be a valuable ﬁrst-level method for
enrichment of TALEN-modiﬁed embryos. Second, although we
did not directly compare TALEN efﬁciency based on scaffold
alone, the GT-TALENs had greater activity than the +231
scaffold in livestock zygotes. In contrast to +231 injected zygotes,
biallelic modiﬁcation was common (25% of modiﬁed embryos)
in zygotes injected with GT–TALEN-pairs in both pigs and
cattle. Finally, there was a pronounced dosage response using
the GT-btGDF83.1 TALENs in terms of activity (43% vs. 75%
mutant blastocysts) and development (24% vs. 8% blast forma-
tion rate) in low- and high-dosage groups, respectively. However,
the ﬁvefold difference between low and high dosage indicates
TALENs function over a broad dosage range, where a balance
between activity and development could be sought. Thus, we
predict that cytoplasmic injection of GT-TALEN mRNA will be
an efﬁcient platform for genetic modiﬁcation of livestock.
Although direct modiﬁcation of zygotic genomes may have
some advantages, somatic cell modiﬁcation followed by cloning
also provides a signiﬁcant advantage by permitting the isolation
of cells containing precise modiﬁcations before the expense of
animal production. We therefore evaluated the use of TALENs
for gene modiﬁcation in primary ﬁbroblasts, the standard cell-
type used for cloning. In agreement with others, we found the
truncated TALEN scaffold was superior for gene modiﬁcation in
primary ﬁbroblasts (15, 20). The efﬁciency of TALEN modiﬁ-
cation could also be improved by culture at 30 °C for 72 h fol-
lowing transfection (22). Combined use of these enhancement
strategies resulted in highly successful TALEN production; 64%
of synthesized pairs were active in ﬁbroblasts with a NHEJ fre-
quency from 1.8 to 40%. Assuming a TALEN-pair introduces
NHEJ at an average efﬁciency of 20%, about ﬁve heterozygous
KOs could be recovered after screening only 24 colonies.
Our transposon coselection strategy (23) in cell populations
was extremely successful for enrichment of indel-positive cells
when transfection was inefﬁcient, and for maintenance of indel-
positive cells when transfection was efﬁcient. When cationic lipid
transfection was used, enrichment for modiﬁed cells was likely
a result of the elimination of nontransfected cells, >95% of total
cells. However, coselection was also capable of preventing an
observed 50–90% loss of TALEN-modiﬁed cells after 14 d
postnucleofection. The reason for modiﬁed-cell attrition is not
clear, although it may be that without selection, cells with a low
level of transgene expression have a growth advantage over cells
with higher levels of expression. Given that coselection was able
to enrich and maintain modiﬁed cells, it seems unlikely that
nuclease off-target activity or toxicity (20, 32) is the cause for
attrition. Instead, selection for antibiotic resistance is likely bi-
ased toward high levels of ectopic gene expression, thereby
enriching for cells in which TALEN expression was also high,
and cleavage more likely to have occurred. Potentially, trans-
position mobilizes the same factors that are involved with repair
after double-stranded DNA cleavage by nucleases. Because
transposition occurs in only a low percentage of transfected cells,
as well as cells in animal tissues (32–34), coselection might enrich
for a subpopulation of cells that were amenable to NHEJ.
By whatever mechanism, transposon coselection was very ef-
fective for the clonal isolation of both mono- and biallelic
TALEN-modiﬁed cells. In fact, an analysis of coselected clones
revealed the frequency of biallelic modiﬁcations to exceed pre-
dictions, assuming each TALEN-induced cleavage/repair was an
independent event. This ﬁnding has also been observed for cells
treated with ZFN’s (11, 35, 36). Furthermore, approximately
two-thirds of the biallelic modiﬁed clones were homozygous for
the same indel, suggesting that gene conversion of TALEN-
mediated genetic changes from the sister chromatid is common,
a bias previously observed by others (37). The efﬁciency of
producing clones with biallelic KO observed here represents
a signiﬁcant improvement over traditional approaches, for which
line breeding or sequential targeting and recloning are required
to generate homozygous KO animals (38). An additional ad-
vantage of nuclease-mediated biallelic KO is that linked selec-
tion markers are not theoretically required. For example, when
the expression of the targeted gene results in a distinguishable
epitope on the cell surface (9), cells harboring a biallelic KO can
be isolated by FACS sorting. Alternatively, cotransfection of
cells with a nonintegrating reporter system enabled the isolation
of cells displaying evidence of nuclease activity at 3 d post-
transfection (39), although inefﬁcient isolation of modiﬁed pri-
mary cell clones (two of six, both monoallelic indels) suggests low
viability among sorted cells. In contrast, transposon coselection
allowed efﬁcient isolation of stable cells containing mono- and
biallelic indels without FACS or a physically linked selection-
marker. These targeted modiﬁcations can be easily segregated
away from the selection transposons in a single generation of
breeding during line propagation (23).
Structural variation in the form of chromosomal deletions,
inversions, and copy number accounts for a signiﬁcant portion of
human genetic variation (40). In this study, we found that large
deletions and inversions could be generated in ﬁbroblasts by
a single cotransfection of two TALEN-pairs that targeted the same
chromosome. The efﬁciency of deletions and inversion in pig
ﬁbroblasts was similar to that reported by others using ZFN to
generate chromosomal deletions in immortalized human cells (41,
42). However, whereas others found cointroduction of two ZFN
pairs often resulted in unintended chromosomal rearrangements
in addition to the desired rearrangement (42), we did not observe
such events, perhaps because we were targeting the hemizygous
DMD locus in male cells. The majority of useful rearrangements
will likely occur on autosomes; therefore, founder lines will have to
be carefully screened to avoid confounding rearrangements.
Chromosomal rearrangements in livestock may also have appli-
cations beyond modeling of human disease. Deletions could be
useful for functional query of gene clusters or used for deletion
mapping of elusive genetic differences identiﬁed in association
studies. Targeted inversions could also theoretically allow ﬁxation
of neighboring trait-determining alleles in a manner analogous to
balancer chromosomes commonly used for genetic studies in lower
eukaryotes. This process could serve as a means to ﬁx a desired
trait or traits in livestock for agricultural purposes or to use non-
disjunction to control the spread of genetically modiﬁed genomes.
Fig. 5. Genotypes of LDLR-knockout Ossabaw swine. The genotypes of 22
cloned piglets were evaluated by cloning and sequencing of amplicons
spanning the LDLR2.1 target site. Four distinct genotypes were identiﬁed and
labeled B1 and B2 for pigs derived from the B pool and C1 and C2 for pigs
derived from the C pool. The wild-type sequence is shown above and the
TALEN recognition sites are indicated in bold. Inserted bases are indicated by
underlined text or denoted with an “i” and number of base pairs.
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The combination of TALENs plus the transposon components
had no apparent impact on the utility of cells for cloning. We
achieved a pregnancy rate of 78% with mono- and biallelic mod-
iﬁed Ossabaw ﬁbroblasts, a rate similar to our previous results with
transposon transgenic Landrace cells (23). This result is especially
encouraging considering that the cloning of Ossabaw swine, which
are superior models of metabolic syndrome, had not previously
been reported. Of the 18 live-born clones, 8 contained monoallelic
mutations and 10 contained biallelic modiﬁcations of the LDLR
gene. These results demonstrate that TALENs can be used to
generate animals with either monoallelic or biallelic gene modiﬁ-
cation by cloning.
TALEN-mediated genome engineering clearly has the capac-
ity to revolutionize genetics and genome engineering in livestock
species by introducing a variety of genomic changes, including
KO, biallelic KO, large chromosomal deletions/inversions, and
potentially, precise allelic introgression. TALENs can be easily
designed and assembled using molecular biology techniques
available in most laboratories. We anticipate that their ease of
use and versatility will rapidly expand the ﬁeld of livestock ge-
nome engineering for a variety of purposes.
Materials and Methods
See SI Materials and Methods for more detail and Tables S4 and S5 for a
complete list of TALENs and PCR primers used in this study. All TALENs were
designed using the TALE-NT software and assembled using methods de-
scribed in Cermak et al. (17), with some modiﬁcations. Four new backbone
plasmids were generated to replace pTAL for the ﬁnal step in TALEN as-
sembly. The ﬁrst pair of vectors, pC-TAL+231 and pC-GoldyTALEN, direct
expression of the +231 (19) and GoldyTALEN scaffolds from the mini Caggs
promoter (43). The second pair of vectors, RCIscript-TAL+231 and RCIscript-
GoldyTALEN, are useful for in vitro transcription of TALEN mRNA based on
the pT3Ts vector previously described (44). The GoldyTALEN vectors have
been made available through Addgene and are fully compatible with the D.
F.V. Laboratory Golden Gate TALEN Kit also available through Addgene
(#1000000016). Intermediary arrays were created and joined into these
vectors, as previously described (17).
TALEN mRNA was synthesized from SacI linearized RCIscript vectors using
the mMessage Machine T3 Kit (Ambion), as previously described (44), and
injected into the cytoplasm at speciﬁed concentrations. Fibroblasts were
cultured and transfected using the Basic Fibroblast Nucleofection Kit (Amaxa
Biosystems/Lonza) or Mirus LT1 reagent (Mirus), as previously described (44).
TALEN activity was analyzed by Surveyor Assay (Transgenomic) and meas-
urements were performed as described in Guschin et al. (45). Indels were
detected in embryos or individual colonies by Surveyor assay or direct se-
quencing. PCR assays described in SI Materials and Methods were developed
to detect large deletions and inversions.
Animal Husbandry/Cloning. Pigs were cloned by CT under contract with
Minitube of America under Recombinetics, Inc.s’ Institutional Animal Care
and Use Committee Protocol 1103A97232 at the University of Minnesota.
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